institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published 2 days ago • loading... • Updated 2 days ago

Prelude Cuts Quarterly Loss as Breast Cancer Trial Nears

Summary by MyChesCo

WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) narrowed its second-quarter loss by more than half and cut research spending as the precision oncology company prepares to move a breast …

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

Prelude Cuts Quarterly Loss as Breast Cancer Trial Nears

WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) narrowed its second-quarter loss by more than half and cut research spending as the precision oncology company prepares to move a breast …

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated2 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MyChesCo broke the news 2 days ago on Tuesday, August 18, 2026.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics